Which of the following is a reason blue dye is no longer recommended for detection of aspiration?

• A. Low sensitivity
• B. Systemic toxicity reports
• C. All of the above
• D. FDA removed Blue #1 from the market in 2003, other blue dyes such as methylene blue and FD&C Blue #2 may have similar or greater toxicity than Blue #1 and are not suitable alternatives

Answer: (C)

Using blue dye to detect aspiration is not recommended because it combines safety concerns with unreliable performance. The dye often has low sensitivity, since tiny amounts of aspirated material may not carry enough dye to produce a visible change, leading to missed aspiration events. There are also systemic toxicity risks if the dye is aspirated and absorbed, potentially causing harmful effects in patients. Regulatory action underscores these safety concerns, such as the FDA removing Blue #1 from market in 2003. Additionally, other blue dyes like methylene blue or FD&C Blue #2 may have similar or greater toxicity, so they aren’t safer alternatives. Because of these factors, blue dye does not provide a reliable or safe method for detecting aspiration, and safer, more accurate methods should be used instead.